Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Code:
NCT04969926
Conditions
Parathyroid Cancer
Primary Hyperparathyroidism
Pseudohypoparathyroidism
Inheritable Bone Diseases
Multiple Endocrine Neoplasia, Type 1
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Parathyroid Cancer
Primary Hyperparathyroidism
Pseudohypoparathyroidism
Inheritable Bone Diseases
Multiple Endocrine Neoplasia, Type 1
Study ID
NCT04969926
Start date
Nov 30, 2021
Status verified date
Aug 20, 2026
Completion date
Jan 22, 2031
Anticipated
Primary completion date
Jan 22, 2031
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Enrollment
3000 participants
Anticipated
Arms
Patients with confirmed, suspected or at risk of developing parathyroid disorder
Primary outcome measure
Central contacts
Locations
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
800-411-1222ccopr@nih.govSponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last update posted
Aug 24, 2026
Last verified
Aug 20, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) on 2026-08-24.